Table 1.
Study name | Countries | Study type | Study years | Type of serodiscordant couples | Number of couples | Number of linked transmissions during study | |
---|---|---|---|---|---|---|---|
Bavinton et al (2018)18 | Opposites Attract | Australia, Brazil, and Thailand | Cohort | 2012–16 | 100% male–male couples | 358 | 0 |
Cohen et al (2016)19 | HPTN 052 | Nine countries worldwide | RCT | 2005–10 | 97% male–female couples and 3% unspecified | 1763 | 46 |
Fideli et al (2001)25 | .. | Zambia | Nested case-control within prospective cohort | 1994–2000 | 100% male–female couples | 1022 (case-control: 109 index transmitters and 208 non-transmitting controls) | 129 |
Mujugira et al (2016)26 | Partners PrEP Study | Kenya and Uganda | Analysis of couples in placebo arm of RCT | 2008–12 | 100% male–female couples | 1573 | Index not on ART: 55; index on ART: 3 |
Quinn et al (2000)20 | Rakai | Uganda | RCT | 1994–98 | 100% male–female couples | 415 | 90* |
Rodger et al (2016)21 | PARTNER | 14 European countries | Cohort | 2010–14 | 62% male–female couples and 38% male–male couples | 1166 | None |
Rodger et al (2019)22 | PARTNER2 | 14 European countries | Cohort | 2010–17 | 100% male–male couples | 972 | None |
Tovanabutra et al (2002)27 | .. | Thailand | Cross-sectional study of wives of HIV-positive men | 1992–98 | 100% male–female couples | 493 | 44% of female partners found to have an HIV-positive serostatus at enrolment* |
ART=antiretroviral therapy. RCT=randomised controlled trial.
Phylogenetic linkage analysis not conducted.